Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice

被引:196
作者
Kreijtz, J. H. C. M. [1 ]
Bodewes, R. [1 ]
van Amerongen, G. [1 ]
Kuiken, T. [1 ]
Fouchier, R. A. M. [1 ]
Osterhaus, A. D. M. E. [1 ]
Rimmelzwaan, G. F. [1 ]
机构
[1] Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands
关键词
cross-protection; CTL; influenza;
D O I
10.1016/j.vaccine.2006.08.036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to assess the level of protection against a lethal influenza virus infection provided by a primary infection with a virus strain of another subtype, C57BL/6 mice were infected with the sublethal influenza virus X-31 (H3N2) and subsequently challenged with the lethal strain A/PR/8/34 (H1N1). The outcome of the challenge infection was compared with that in mice that did not experience an infection with influenza virus X-31 prior to the challenge infection. The X-31 experienced mice cleared the infection with influenza virus A/PR/8/34 in ail accelerated fashion, displayed less clinical signs and a reduction of lesions in the lungs resulting in improved survival rates of these mice compared to the naive mice. The improved outcome of the challenge infection with influenza virus A/PR/8/34 in the X-31 experienced mice correlated with priming for anamnestic virus-specific CD8(+) cytotoxic T lymphocyte (CTL) responses as was demonstrated by the detection of CTL specific for the H-2D(b) restricted NP366-374 epitope that was shared by the influenza viruses X-31 and A/PR/8/34. Thus previous exposure to influenza A viruses affords partial protection against infection in the absence of virus-neutralizing antibodies specific for the hemagglutinin and the neuraminidase. The implications of these observations are discussed in the light of the current pandemic threat and development of vaccines that aim at the induction of virus-specific CTL. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 51 条
[1]  
Aubin JT, 2005, EMERG INFECT DIS, V11, P1515
[2]   GENE COMPOSITION OF HIGH-YIELDING INFLUENZA VACCINE STRAINS OBTAINED BY RECOMBINATION [J].
BAEZ, M ;
PALESE, P ;
KILBOURNE, ED .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (03) :362-365
[3]   Current concepts - Avian influenza A (H5N1) infection in humans [J].
Beigel, H ;
Farrar, H ;
Han, AM ;
Hayden, FG ;
Hyer, R ;
de Jong, MD ;
Lochindarat, S ;
Tien, NTK ;
Hien, NT ;
Hien, TT ;
Nicoll, A ;
Touch, S ;
Yuen, KY .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385
[4]   A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge [J].
Belz, GT ;
Xie, WD ;
Altman, JD ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3486-3493
[5]   Diversity of epitope and cytokine profiles for primary and secondary influenza A virus-specific CD8+ T cell responses [J].
Belz, GT ;
Xie, WD ;
Doherty, PC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4627-4633
[6]   TRANSGENIC MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED T-CELLS HAVE DELAYED VIRAL CLEARANCE AND INCREASED MORTALITY AFTER INFLUENZA-VIRUS CHALLENGE [J].
BENDER, BS ;
CROGHAN, T ;
ZHANG, LP ;
SMALL, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1143-1145
[7]   Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells [J].
Benton, KA ;
Misplon, JA ;
Lo, CY ;
Brutkiewicz, RR ;
Prasad, SA ;
Epstein, SL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7437-7445
[8]  
Cassetti Maria Cristina, 2006, Vaccine, V24, P541, DOI 10.1016/j.vaccine.2005.08.051
[9]  
Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004
[10]   Human disease from influenza A (H5N1), Thailand, 2004 [J].
Chotpitayasunondh, T ;
Ungchusak, K ;
Hanshaoworakul, W ;
Chunsuthiwat, S ;
Sawanpanyalert, P ;
Kijphati, R ;
Lochindarat, S ;
Srisan, P ;
Suwan, P ;
Osotthanakorn, Y ;
Anantasetagoon, T ;
Kanjanawasri, S ;
Tanupattarachai, S ;
Weerakul, J ;
Chaiwirattana, R ;
Maneerattanaporn, M ;
Poolsavatkitikool, R ;
Chokephaibulkit, K ;
Apisarnthanarak, A ;
Dowell, SF .
EMERGING INFECTIOUS DISEASES, 2005, 11 (02) :201-209